Donglin Sun | Prostate Cancer | Best Researcher Award

Posted on 17/03/202517/03/2025 by Pencis

Dr. Donglin Sun | Prostate Cancer | Best Researcher Award

Southern Medical University | China

AUTHOR PROFILE

🔬SUN DONGLIN – MEDICAL DOCTOR IN ONCOLOGY

📚EARLY ACADEMIC PURSUITS

Sun Donglin began his academic journey at No.1 Middle School of Fuyang, Anhui Province (2005-2008). His strong foundation in science led him to pursue a Bachelor’s Degree in Clinical Medicine at Bengbu Medical College (2008-2013), where he developed a keen interest in oncology. His dedication and passion for medical research culminated in a PhD in Oncology through the Master-Doctor Continuous Program at the Affiliated Cancer Hospital of Guangzhou Medical University (2018-2023). He was recognized as an “Outstanding Graduate Student” and “Excellent Graduate”, a testament to his academic excellence and research contributions.

🏥PROFESSIONAL ENDEAVORS

Sun Donglin’s clinical training and professional career reflect a steady progression in expertise:

2013 – 2016: Surgical Resident, Third Affiliated Hospital of Sun Yat-sen University – Gained hands-on experience in surgical oncology.
2016 – 2018: Urology Resident Physician, Shenzhen Hospital of Southern Medical University – Developed a specialization in urological oncology.
2023 – Present: Urology Associate Chief Physician, Shenzhen Hospital of Southern Medical University – Achieved Associate Chief Physician Certification in 2020, demonstrating his leadership in urologic oncology and clinical excellence.

🔍RESEARCH FOCUS

Sun Donglin’s research focuses on two critical areas in oncology:

Mechanisms of Non-Canonical NF-κB Signaling in Renal Fibrosis – Investigating how alternative pathways of NF-κB contribute to fibrosis, which has significant implications for kidney disease treatments.
Drug Resistance Mechanisms in Prostate Cancer – Exploring molecular resistance pathways in prostate cancer to enhance therapeutic strategies and overcome treatment barriers.

💡CONTRIBUTIONS TO SCIENTIFIC RESEARCH

Sun Donglin has led and participated in several high-impact research projects:

Principal Investigator:
- National Natural Science Foundation of China (Youth Program) – 300,000 RMB (2025-2027) (Approval No.: 82400789)
- Guangdong Provincial Medical Science and Technology Research Fund – 10,000 RMB (2024-2026) (Approval No.: A2024317)
- Southern Medical University National Natural Science Foundation Cultivation Program – 100,000 RMB (2024-2026) (Approval No.: 23H3AGZR02)
Key Participant in Major Research Projects:
- National Natural Science Foundation of China Major Research Program Cultivation Project – 680,000 RMB (2020-2022) (Approval No.: 91949102)
- National Natural Science Foundation of China General Program – 570,000 RMB (2019-2022) (Approval No.: 81874095)

🌍IMPACT AND INFLUENCE 🌍

Sun Donglin’s research has contributed to a deeper understanding of renal fibrosis mechanisms and drug resistance in prostate cancer. His work has the potential to improve therapeutic interventions and patient outcomes, particularly in treatment-resistant prostate cancer cases. His collaborations in major national projects highlight his role as an emerging leader in oncological research.

🏅ACADEMIC CITES AND RECOGNITION

Recognized as an Outstanding Graduate Student and Excellent Graduate during his PhD.
His research findings are gaining recognition in top-tier oncology journals, further solidifying his influence in the field.
Contributions to multi-million RMB-funded research projects, showcasing his ability to secure competitive grants.

🌱LEGACY AND FUTURE CONTRIBUTIONS

Sun Donglin’s work will shape the future of oncology therapeutics and urological oncology. His research on non-canonical NF-κB signaling could unlock new pathways for renal fibrosis treatment, while his studies on prostate cancer drug resistance could lead to novel therapeutic strategies.

Moving forward, he aims to:
✅ Expand research collaborations internationally to enhance the impact of his studies.
✅ Develop translational therapies targeting NF-κB signaling in fibrosis and prostate cancer.
✅ Mentor young oncologists and researchers to foster the next generation of medical scientists.

🌍CONCLUSION

Dr. Sun Donglin is a rising leader in oncology research and urological oncology, with a strong foundation in both clinical practice and scientific innovation. His expertise in non-canonical NF-κB signaling in renal fibrosis and drug resistance in prostate cancer has positioned him as a key contributor to the advancement of cancer therapeutics.

📊🔬NOTABLE PUBLICATION:

Title: Serum RelB is correlated with renal fibrosis and predicts chronic kidney disease progression
Authors: Sun, D., Xie, N., Wang, X., Wu, W., Li, X. Y., Chen, X., Qian, G., Li, C., Zhang, H., Jiang, Y., Ye, D., Liu, D., Hu, Y., Wang, J., Chen, W., Zhao, Q., Zeng, M., Zhang, J., Wang, L., & Zhang, X
Journal: Clinical and Translational Medicin
Year: 2021

Title: B-cell-derived IL-10 promotes allergic sensitization in asthma regulated by Bcl-3.
Authors: Qian, G., Jiang, W., Sun, D., Sun, Z., Chen, A., Fang, H., Wang, J., Liu, Y., Yin, Z., Wei, H., Fang, H., & Zhang, X.
Journal: Cellular & Molecular Immunology
Year: 2023

Title: Development of RelB-Targeting Small Molecule Inhibitors of Non-canonical NF-κB Signaling with Antitumor Efficacy
Authors: Li, C., Wei, S., Sun, D., Yang, Z., Wang, Q., Lin, H., Zhang, H., Hu, Y., Liu, D., Ye, D., Tao, Y., Liu, Z., Xu, Z., Li, B., Li, L., Zhang, J., Chen, X., Xie, N., Shi, Y., Liu, S., Liu, Y., Jiang, Y., Zhu, W., & Zhang, X.
Journal: Molecular Therapy
Year: 2025

Title: LKB1 activated by NaB inhibits the IL-4/STAT6 axis and ameliorates renal fibrosis through the suppression of M2 macrophage polarization.
Authors: Liang, W., Wu, H., Long, Q., Lin, H., Lv, X., Ma, W., Wu, T., Ai, L., Zheng, Q., Guo, J., Chen, X., Guo, J., & Sun, D..
Journal: Life Sciences
Year: 2025

Title: Integrative analysis of potential diagnostic markers and therapeutic targets for glomerulus-associated diabetic nephropathy based on cellular senescence
Authors: Sun, D., Wei, S., Wang, D., Zeng, M., Mo, Y., Li, H., Liang, C., Li, L., Zhang, J. W., & Wang, L
Journal: Frontiers in Immunology
Year: 2023

yuchang li | Chinese Medicine | Best Researcher Award

Posted on 15/03/202515/03/2025 by Pencis

Mr. yuchang li | Chinese Medicine | Best Researcher Award

Shanxi University of Chinese Medicine | China

AUTHOR PROFILE

ORCID ID

🎓 EARLY ACADEMIC PURSUITS

Yu-chang Li is currently a student at Shanxi University of Chinese Medicine, enrolled in the Third Clinical College of Clinical Medicine, specializing in Traditional Chinese and Western Medicine. From an early stage in his academic journey, he has demonstrated a strong passion for integrating traditional Chinese medicine (TCM) with modern medical approaches. His commitment to research and academic excellence has been recognized through numerous awards and publications.

🏆 PROFESSIONAL ENDEAVORS

Yu-chang Li has made significant contributions to medical research, particularly in the field of oncology alternative medicine. His work bridges the gap between traditional Chinese medicine and Western medical practices, exploring innovative therapeutic approaches to combat life-threatening diseases.

His achievements include:
✅ Winner of multiple prestigious awards, including:

National Silver Award at the 10th National College Students Basic Medical Innovation Research and Experimental Design Forum
Provincial Silver Award
Provincial Bronze Award

✅ Published two SCI-indexed research papers, demonstrating expertise in oncology and alternative medicine.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON CHINESE MEDICINE

Yu-chang Li’s research is centered on the role of Chinese herbal medicine in oncology, with a particular focus on the immunomodulatory effects of Astragalus membranaceus (Huangqi) and other herbal formulations.

🔹 Astragalus Injection and Osteosarcoma
One of his landmark studies, Astragalus Injection Inhibits the Growth of Osteosarcoma by Activating Cytotoxic T Lymphocyte and Targeting CTSL, investigates the use of Huangqi Injection (HQI) in treating osteosarcoma. His research highlights the immunomodulatory potential of HQI, demonstrating that its active component, Cycloastragenol (CG), enhances immune response and targets CTSL, leading to tumor suppression.

🔹 Shenqi Granules and Cerebral Ischemia-Reperfusion Injury
In another study, Shenqi Granules Enhance Recovery from Cerebral Ischemia-Reperfusion Injury by Modulating Tryptophan and Tyrosine Metabolism and Activating NFE2L2/NRF2, he explores the neuroprotective effects of Shenqi granules. His findings contribute to stroke rehabilitation research, emphasizing the potential of herbal formulations in neurological recovery.

His research provides scientific validation for traditional Chinese medicine (TCM) therapies, paving the way for their integration into modern medical treatments.

🌍 IMPACT AND INFLUENCE

Yu-chang Li’s research has had a profound impact on both oncology and alternative medicine by:
📌 Advancing integrative medicine through scientific validation of herbal treatments.
📌 Contributing to cancer immunotherapy using TCM-based approaches.
📌 Providing new perspectives on the treatment of osteosarcoma and stroke recovery.
📌 Inspiring future researchers to explore synergistic applications of Chinese and Western medicine.

📖 ACADEMIC CITATIONS AND RECOGNITION

As a young scholar, Yu-chang Li’s publications have gained recognition in the scientific community, contributing valuable insights to the fields of Chinese medicine and oncology. His work is frequently cited by researchers investigating herbal immunotherapy, oncology treatments, and neuroprotection strategies.

🔮 LEGACY AND FUTURE CONTRIBUTIONS

Yu-chang Li is poised to become a leading figure in integrative medicine, focusing on oncology and alternative therapies. His future contributions may include:
✨ Developing new herbal formulations for cancer treatment.
✨ Conducting clinical trials to further validate TCM therapies.
✨ Bridging the gap between traditional and modern medicine.
✨ Expanding the global acceptance of TCM in cancer care.

His research and innovations will undoubtedly shape the future of medicine, providing safe, effective, and scientifically backed treatments that integrate the wisdom of traditional Chinese medicine with modern scientific advancements.

🌍CONCLUSION

Yu-chang Li is a rising scholar in integrative medicine, dedicated to advancing the scientific understanding of Traditional Chinese Medicine (TCM) and its applications in oncology and neurological disorders. His research on Astragalus Injection in osteosarcoma and Shenqi granules in stroke recovery showcases the therapeutic potential of herbal medicine, reinforcing the importance of evidence-based alternative treatments.

📊🔬NOTABLE PUBLICATION:

Title: Shenqi granules enhance recovery from cerebral ischemia-reperfusion injury by modulating tryptophan and tyrosine metabolism and activating NFE2L2/NRF2.
Authors: Liu HX, Yang MK, Li YC, Liu CX, Li GP, Meng XL, Pei K, Wen SY
Journal: International Journal of Phytotherapy and Phytopharmacology
Year: 2025

Title: Astragalus injection inhibits the growth of osteosarcoma by activating cytotoxic T lymphocyte and targeting CTSL.
Authors: Liu HX, Li YC, Su RB, Liu CX, Wen SY.
Journal: Journal of Ethnopharmacology
Year: 2025

Yunsheng Yang | Inflammatory Bowel Disease | Best Researcher Award

Posted on 19/02/202522/02/2025 by Pencis

Prof. Dr. Yunsheng Yang | Inflammatory Bowel Disease | Best Researcher Award

The First Medical Center, Chinese PLA General Hospital | China

AUTHOR PROFILE

ORCID ID

🌟YUNSHENG YANG, M.D. – A LEADER IN GASTROENTEROLOGY 🏥

🎓EARLY ACADEMIC PURSUITS

Dr. Yunsheng Yang earned his M.D. from the First Military Medical University in 1995, laying the foundation for his illustrious medical career. He pursued postdoctoral training at the Fourth Military Medical University in China, further honing his expertise in gastroenterology. His academic journey extended internationally with visiting scholar positions at the University of Sydney’s Westmead Hospital in 2008 and Mayo Clinic Rochester in 2014, where he gained invaluable global exposure to advanced medical practices.

👩‍🏢PROFESSIONAL ENDEAVORS

Currently, Dr. Yang serves as the Academic Director of the Department of Gastroenterology and Hepatology at the First Medical Center, Chinese PLA General Hospital (PLAGH, 301 Hospital) in Beijing, China. His leadership extends beyond national borders, with visiting or adjunct professorships at Shenzhen University, Universitas Amoiensis, and the University of Michigan, USA.

His involvement in prestigious medical societies includes being the immediate past president of the Chinese Society of Gastroenterology and the Director of the APSDE Training Center in PLAGH since 2006. Dr. Yang actively engages with the World Gastroenterology Organization (WGO), serving as a scientific committee member and having previously contributed to the WGO Endoscopy Group and Nomination Committee.

🔬CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Yang’s clinical expertise primarily revolves around gastrointestinal (GI) disorders and therapeutic Endoscopic Retrograde Cholangiopancreatography (ERCP). His research is focused on robot-assisted endoscopy and GI microbiota, where he has pioneered multiple innovative procedures in China, including:

Endoscopic suturing for GERD (2001)
Double balloon enteroscopy (2003)
Peroral video cholangioscopy and laser lithotripsy (2004)
Confocal endomicroscopy (2006)
MUSE for GERD (2017)
Fecal Microbiota Transplantation (FMT) clinical trials for IBD, autism, and Tourette syndrome (since 2014)

Notably, he led the development of the YunSRobot, a robot-assisted GI endoscopy system, successfully performing gastroscopy on human volunteers in 2017 and completing remote gastroscopy in 2021. These groundbreaking achievements have been published and indexed in PubMed.

📚IMPACT AND INFLUENCE

Dr. Yang’s influence in the field of gastroenterology is reflected in his extensive publication record. He has authored over 200 articles in Chinese journals and more than 150 papers in international SCI-indexed journals, including prestigious titles such as Gastroenterology, Hepatology, The American Journal of Gastroenterology (AJG), Gastrointestinal Endoscopy (GIE), Alimentary Pharmacology & Therapeutics (AP&T), and Gut.

As an editorial board member for Gut and AP&T, and associate editor for MMR and JDD, he continues to shape the direction of gastroenterology research and clinical practice worldwide.

🌟ACADEMIC CITES AND RECOGNITION

Dr. Yang’s research contributions have been extensively cited by peers in the medical and scientific communities. His innovations in endoscopic procedures and gastrointestinal microbiota research have influenced treatment protocols and technological advancements in digestive health worldwide. His pioneering work on FMT for neurological conditions and robotic-assisted endoscopy is setting new standards in precision medicine.

💪LEGACY AND FUTURE CONTRIBUTIONS

Dr. Yang’s enduring legacy lies in his transformative impact on gastroenterology, blending cutting-edge technology with clinical expertise. His leadership in developing robotic-assisted endoscopy has the potential to revolutionize non-invasive diagnostics and treatment, paving the way for AI-integrated endoscopic procedures.

Looking ahead, Dr. Yang continues to push the boundaries of GI research, particularly in the integration of robotics, microbiota-based therapies, and novel endoscopic interventions. His mentorship of young gastroenterologists ensures a lasting impact on the field, fostering the next generation of leaders in digestive health research and clinical innovation.

🌍CONCLUSION

Dr. Yunsheng Yang stands as a trailblazer in the field of gastroenterology, with his extensive contributions in clinical practice, research, and technological innovation. His groundbreaking advancements in robot-assisted endoscopy and GI microbiota research have set new benchmarks in the medical field. His dedication to patient care, scientific discovery, and mentorship ensures his influence will resonate for years to come, shaping the future of digestive health worldwide.

📊🔬NOTABLE PUBLICATION:

Title: Fecal microbiota transplantation significantly improved respiratory failure of amyotrophic lateral sclerosis.
Authors: Yan J, Chen H, Zhang Y, Peng L, Wang Z, Lan X, Yu S, Yang Y.
Year: 2024

Title: Dynamic changes in the gut microbiota after bismuth quadruple therapy and high-dose dual therapy for Helicobacter pylori eradication.
Authors: Chen J, Zhang Y, Min H, Zhi J, Ma S, Dong H, Yan J, Chi X, Zhang X, Yang Y.
Year: 2024

Title: Colorectal cancer and gut microbiota studies in China.
Authors: Wang Z, Dan W, Zhang N, Fang J, Yang Y.
Year: 2023

Title: The fecal microbiota from children with autism impact gut metabolism and learning and memory abilities of honeybees.
Authors: Li Y, Zhang Y, Luo X, Meng Y, Zhong Z, Zheng H, Yang Y.
Year: 2023

Title: Deep insights into the gut microbial community of extreme longevity in South Chinese centenarians by ultra-deep metagenomics and large-scale culturomics.
Authors: Li C, Luan Z, Zhao Y, Chen J, Yang Y, Wang C, Jing Y, Qi S, Li Z, Guo H, et al.
Year: 2022

Lin Zhao | Neuropathic Pain | Best Researcher Award

Posted on 13/02/202522/02/2025 by Pencis

Prof. Dr. Lin Zhao | Neuropathic Pain | Best Researcher Award

China Medical university | China

AUTHOR PROFILE

Scopus

👨‍🎓 EARLY ACADEMIC PURSUITS

Prof. Dr. Lin Zhao began his academic journey with a strong foundation in medical sciences and neuroscience. He pursued his undergraduate and graduate studies at prestigious institutions, focusing on the mechanisms of neuropathic pain. His passion for understanding pain pathways led him to China Medical University, where he honed his expertise in neurobiology, pain modulation, and therapeutic interventions.

🏥 PROFESSIONAL ENDEAVORS

Dr. Zhao holds a key academic and research position at China Medical University. Over the years, he has been involved in:

Leading groundbreaking research in the field of neuropathic pain.
Mentoring Ph.D. and postgraduate students specializing in pain research.
Collaborating with international institutions to develop novel pain therapies.
Serving on editorial boards and scientific committees, contributing to the peer-review process of major pain-related journals.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Zhao’s research focuses on neuropathic pain mechanisms, pain signaling pathways, and novel treatment strategies. His key contributions include:

Uncovering the molecular and cellular basis of chronic pain conditions.
Exploring innovative drug targets for pain management.
Developing non-invasive pain therapies such as neurostimulation and pharmacological interventions.
Publishing high-impact research papers in international medical journals.

🌍 IMPACT AND INFLUENCE

Dr. Zhao’s research has had a profound impact on the medical field, particularly in:

Advancing clinical treatments for neuropathic pain.
Enhancing the understanding of chronic pain disorders and their underlying causes.
Shaping medical guidelines and therapeutic approaches in pain management.
Influencing pain research globally through his findings and collaborations.

📚 ACADEMIC CITATIONS AND RECOGNITION

Prof. Zhao has received numerous citations for his work in neuropathic pain, reflecting his scientific influence. His H-index and impact factor stand as a testament to his significant contributions. He has also:

Published extensively in SCI-indexed journals.
Received prestigious research grants and awards.
Been recognized as a leading figure in the field of pain research.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Dr. Zhao’s legacy in neuropathic pain research continues to grow. His future contributions may include:

Pioneering new pain relief therapies using cutting-edge technologies.
Expanding his mentorship programs to nurture the next generation of pain researchers.
Enhancing interdisciplinary collaborations to integrate neuroscience, pharmacology, and biomedical engineering for better treatment solutions.
Driving policy changes in pain management and healthcare systems.

🎯 FINAL THOUGHTS

Prof. Dr. Lin Zhao stands as a pillar in neuropathic pain research, with his work paving the way for more effective, patient-centered treatments. His dedication to science, innovation, and education ensures that his contributions will continue to shape the field for years to come.

🏆 CONCLUSION

Prof. Dr. Lin Zhao has revolutionized the field of neuropathic pain research, making significant scientific and clinical advancements that have shaped modern pain management strategies. His dedication to understanding pain mechanisms, developing novel therapies, and mentoring future researchers has established him as a leading expert in the field.

📊🔬NOTABLE PUBLICATION:

Title: Astaxanthin alleviates spinal nerve ligation-induced neuropathic pain by modulating propionic acid levels
Authors: J., Li, Jingwu , D., Dong, Daosong , Y., Sun, Yanbin , … K., Wang, Kunpeng , L., Zhao, Lin
Journal: Phytomedicine
Year: 2025

Title: Astaxanthin alleviates neuropathic pain by inhibiting the MAPKs and NF-κB pathways
Authors: Lin Zhao; Xueshu Tao; Tao Song;
Journal: Pharmacology
Year: 2021

Title: Astaxanthin alleviates inflammatory pain by regulating the p38 mitogen-activated protein kinase and nuclear factor-erythroid factor 2-related factor/heme oxygenase-1 pathways in mice
Authors: Lin Zhao; Xueshu Tao; Chengfu Wan; Daosong Dong; Chenglong Wang; Qi Xi; Yan Liu; Tao Song;
Journal: Food & Function
Year: 2021

Title: Short-Term Spinal Cord Stimulation and Peripheral Nerve Stimulation for the Treatment of Trigeminal Postherpetic Neuralgia in Elderly Patients
Authors: Zhao, Lin; Song, Tao
Journal: Frontiers in Neurology
Year: 2021

Kalim Ullah | Molecular Biology | Best Researcher Award

Posted on 10/02/202511/04/2025 by Pencis

Dr. Kalim Ullah | Molecular Biology | Best Researcher Award

Ningbo university China | China

Author Profile

ORCID ID

🧬 Dr. Kalim Ullah – Molecular Biologist & Aquaculture Researcher 🐟🔬

Dr. Kalim Ullah is a dedicated researcher with a strong background in molecular biology, genetics, immunology, and aquaculture. His expertise lies in understanding the genetic and cellular mechanisms underlying aquatic species’ development, regeneration, and immune responses.

🎓 Education & Academic Excellence

Ph.D. in Aquaculture – Ningbo University, China
Focus: Genetics, Molecular Biology & Immunology (CGPA: 3.75/4.00)
M.Phil. in Zoology – PMAS-Arid Agriculture University, Pakistan
Focus: Aquaculture & Fisheries (CGPA: 3.68/4.00)
BS (Hons) in Zoology – University of Peshawar, Pakistan
Focus: Aquaculture & Fisheries (CGPA: 3.6/4.0)
Higher Secondary & Secondary Education – Pakistan

🔬 Research Interests

✔ Molecular Biology
✔ Genetics
✔ Cell Biology & Immunology

🧪 Research Projects

📌 Ph.D.: Comparative transcriptome analysis & epigenetic profiling in silver pomfret caudal fin regeneration.
📌 M.Phil.: Effect of stocking density on growth performance of Indus Mahseer (Tor Maccrolepis).
📌 BS: Utilization of poultry farm waste as a protein and energy source in Labeo rohita diets.

💻 Technical Skills

Dr. Kalim Ullah continues to push the boundaries of genetics, aquaculture, and immunology, contributing valuable insights to the scientific community. 🚀🔬🐠

🏆 CONCLUSION

Dr. Kalim Ullah is a passionate and accomplished researcher at the intersection of molecular biology, genetics, immunology, and aquaculture. With a strong academic background, hands-on laboratory expertise, and a keen interest in advanced genetic and cellular studies, he is dedicated to driving scientific progress in aquatic species research, regenerative biology, and immune system studies. His contributions to transcriptomics, proteomics, and genome analysis highlight his ability to tackle complex biological challenges.

📊🔬NOTABLE PUBLICATION:

Title: Target miRNA identification for the LPL gene in large yellow croaker (Larimichthys crocea)
Authors: Kalim Ullah; Aslam Hossain; Mingyue Cao; Liangyi Xue; Yajun Wang
Journal: Scientific Reports
Year: 2025

Title: Teleost Caudal Fin Development and Regeneration: Mechanisms, Models, and Therapeutic Potential
Authors: Kalim Ullah, Rakhshanda Rani, Fouzia Shaheen, Faisal Tasleem
Journal: Asian Journal of Fisheries and Aquatic Research
Year: 2024

Yubing Wang | Oncology | Best Researcher Award

Posted on 10/02/202510/02/2025 by Pencis

Assoc. Prof. Dr. Yubing Wang | Oncology | Best Researcher Award

Weifang No.2 People’s Hospital | China

AUTHOR PROFILE

Scopus

🔬 EARLY ACADEMIC PURSUITS

Yubing Wang embarked on his academic journey with a strong foundation in biosciences. In 2007, he earned his Bachelor’s degree in Bioscience from Shandong University, which laid the groundwork for his future endeavors in the field of biological and medical sciences. His passion for scientific research led him to pursue further studies, culminating in a Doctor of Science degree from The Chinese University of Hong Kong in 2017. This rigorous academic training provided him with expertise in advanced biological sciences and research methodologies, setting the stage for his future contributions to medical and bioscience research.

🏥 PROFESSIONAL ENDEAVORS

Dr. Wang’s professional career is marked by significant roles in both research and academia. His journey began as a Research Assistant at the Shanghai Institutes for Biological Sciences, CAS, where he worked for six years (2007–2013), gaining hands-on experience in cutting-edge biological research. Following this, he transitioned into academia, taking on the role of Associate Professor at Shandong Second Medical University from 2018 to 2023. His commitment to teaching and research was further recognized when he joined Weifang No.2 People’s Hospital as an Associate Professor in 2023, where he continues to contribute to the advancement of medical sciences.

📚 CONTRIBUTIONS AND RESEARCH FOCUS ON ONCOLOGY

Dr. Wang’s research is centered around biosciences and medical applications, particularly in biological mechanisms and therapeutic developments. His work has contributed to a deeper understanding of biomedical sciences, with a focus on improving clinical outcomes through innovative research. His interdisciplinary approach combines molecular biology, biotechnology, and clinical applications, addressing critical medical challenges and advancing healthcare solutions.

🌍 IMPACT AND INFLUENCE

Throughout his career, Dr. Wang has played a pivotal role in bridging the gap between fundamental bioscience research and its practical applications in medicine. His work has influenced both the academic community and clinical practices, contributing to the development of novel medical treatments and diagnostic tools. By mentoring students and collaborating with fellow researchers, he has fostered a new generation of scientists committed to pushing the boundaries of medical research.

📖 ACADEMIC CITATIONS AND RECOGNITION

Dr. Wang’s research has been widely recognized in the academic community, with numerous scientific publications in reputed journals. His work has been cited by fellow researchers, reflecting the significance and impact of his contributions to biosciences and medical research. His research has also been instrumental in guiding clinical practices and informing new treatment methodologies.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

As an esteemed academic and researcher, Dr. Wang continues to expand his influence in bioscience and medical research. His future endeavors aim to enhance interdisciplinary research collaborations, further the development of innovative healthcare solutions, and mentor the next generation of scientists and medical professionals. His work at Weifang No.2 People’s Hospital is expected to drive forward transformative research, ultimately improving patient care and advancing medical knowledge.

🏆 CONCLUSION

Dr. Yubing Wang’s career exemplifies a commitment to scientific excellence, academic mentorship, and transformative medical research. His contributions in biosciences and medicine have left a lasting impact on both academia and clinical practice. With his expertise and dedication, he continues to shape the future of biomedical research, paving the way for groundbreaking discoveries and improved healthcare outcomes. His legacy as a researcher and educator ensures that his influence will be felt for generations to come.

📊🔬NOTABLE PUBLICATION:

Title: Improved efficacy of cisplatin delivery by peanut agglutinin‑modified liposomes in non‑small cell lung cancer
Authors: B., Yang, Ben , R., Kou, Rongguan , H., Wang, Hui , … W., Yu, Wenjing , Z., Gao, Zhiqin
Journal: International Journal of Molecular Medicine
Year: 2024

Title: Novel analgesic peptide derived from Cinobufacini injection suppressing inflammation and pain via ERK1/2/COX-2 pathway
Authors: L., Guo, Li , S., Zhang, Sai , C., Zhang, Cong , … Y., Gao, Yuanyuan , T., Sun, Tongyi
Journal: International Immunopharmacology
Year: 2024

Di Fan | Molecular Imaging in Drug Development | Best Researcher Award

Posted on 08/02/202510/02/2025 by Pencis

Ms. Di Fan | Molecular Imaging in Drug Development | Best Researcher Award

Capital Medical University | China

AUTHOR PROFILE

Scopus

📌 DI FAN, PhD

Associate Researcher
Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University

🎓 EDUCATION AND EARLY ACADEMIC PURSUITS

Di Fan pursued his Bachelor’s degree at Wuhan University (2006-2010), where he built a strong foundation in biomedical sciences. His passion for advanced medical research led him to Peking University (2010-2015), where he obtained his PhD. During his doctoral studies, he focused on radiopharmaceuticals and molecular imaging, setting the stage for a career dedicated to cutting-edge advancements in nuclear medicine.

🏥 PROFESSIONAL ENDEAVORS

Currently serving as an Associate Researcher at the Department of Nuclear Medicine, Beijing Tiantan Hospital, Capital Medical University, Di Fan plays a pivotal role in advancing molecular imaging and targeted cancer therapies. His work bridges the gap between innovative radiopharmaceuticals and their clinical applications, contributing to the early detection and treatment of cancer.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS

Dr. Fan’s research is primarily focused on:

Radiopharmaceutical Development – Designing novel radioactive tracers for precise cancer imaging and treatment.
Molecular Imaging – Utilizing advanced PET and SPECT imaging techniques to enhance tumor detection and therapeutic monitoring.
Targeted Cancer Therapy – Developing radiolabeled compounds to selectively attack cancer cells, minimizing damage to healthy tissues.

His work contributes significantly to improving personalized cancer treatment, ensuring higher accuracy in diagnosis and therapy.

🌍 IMPACT AND INFLUENCE

Dr. Fan’s contributions have been recognized through numerous scientific publications, collaborations with leading medical institutions, and participation in national and international research projects. His expertise in nuclear medicine and molecular imaging has influenced both clinical practices and medical innovations in China and beyond.

📚 ACADEMIC CITES AND RECOGNITION

Published extensively in high-impact SCI-indexed journals related to radiopharmaceuticals and cancer imaging.
H-index and citations reflect his significant contribution to the field of nuclear medicine.
Regularly invited to present at global medical and radiology conferences, sharing insights on novel imaging techniques.

🚀 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Fan aims to:
✅ Develop next-generation radiopharmaceuticals for better cancer detection and treatment.
✅ Strengthen collaborations between academic and clinical institutions to enhance nuclear medicine applications.
✅ Advance precision oncology, integrating AI-driven analysis for personalized cancer therapies.

His research will continue shaping the future of molecular imaging and targeted therapies, ensuring breakthroughs in early cancer diagnosis and patient-centered treatments.

🧬CONCLUSION

Dr. Di Fan stands at the forefront of nuclear medicine research, making significant strides in radiopharmaceuticals, molecular imaging, and targeted cancer therapy. His dedication to scientific innovation and clinical application has not only enhanced cancer diagnostics and treatment but also paved the way for more effective and personalized medical approaches.

Jianqiang Wu | Melanoma | Best Researcher Award

Posted on 08/02/202508/02/2025 by Pencis

Mr. Jianqiang Wu | Melanoma | Best Researcher Award

Guangzhou Medical University | China

AUTHOR PROFILE

ORCID ID

🏥MR. JIANQIANG WU: ACADEMIC AND PROFESSIONAL PROFILE

🎓EARLY ACADEMIC PURSUITS

Mr. Jianqiang Wu pursued his medical education with a focus on dermatology, establishing a strong foundation in medical sciences. His early academic years were marked by rigorous training, research involvement, and a keen interest in skin-related disorders, particularly melanoma.

🩺PROFESSIONAL ENDEAVORS

Currently serving at the Department of Dermatology, the Affiliated Panyu Central Hospital, Guangzhou Medical University, China, Mr. Wu has been an integral part of the institution’s dermatological research and clinical services. His dedication to patient care and medical research has significantly contributed to advancements in dermatology.

🔬CONTRIBUTIONS AND RESEARCH FOCUS

Mr. Wu has dedicated a substantial part of his career to the study and treatment of melanoma, a serious form of skin cancer. His research focuses on early diagnosis, innovative treatments, and improving therapeutic outcomes for melanoma patients. He has played a pivotal role in developing targeted therapies and exploring the genetic and molecular mechanisms underlying melanoma progression.

🌍IMPACT AND INFLUENCE

Through his research and clinical practice, Mr. Wu has influenced the field of dermatology, particularly in the early detection and treatment of melanoma. His work has led to improved diagnostic techniques and treatment protocols, benefiting patients in China and beyond. His contributions to medical education have also guided the next generation of dermatologists.

📚ACADEMIC CITATIONS

Mr. Wu’s research findings have been widely cited in peer-reviewed journals, reflecting their significance in the scientific community. His publications contribute to a growing body of knowledge in dermatology, particularly in melanoma treatment strategies.

🏆LEGACY AND FUTURE CONTRIBUTIONS

With a strong track record in clinical and academic dermatology, Mr. Wu’s legacy is marked by his commitment to advancing melanoma research. His future endeavors may include further innovation in personalized medicine, novel therapeutic approaches, and international collaborations to combat skin cancer more effectively.

💊OTHER IMPORTANT TOPICS

Collaborations: Engages in interdisciplinary collaborations with oncologists, geneticists, and immunologists to enhance melanoma treatment.
Mentorship: Actively mentors young dermatologists, contributing to the academic and professional growth of upcoming medical professionals.
Public Health Initiatives: Involved in skin cancer awareness campaigns, promoting early detection and prevention measures in the community.
Technological Integration: Advocates for the use of AI and advanced imaging technologies in dermatological diagnostics.

🧬CONCLUSION

Mr. Jianqiang Wu has made remarkable contributions to the field of dermatology, particularly in melanoma research and treatment. His dedication to patient care, innovative research, and academic mentorship ensures that his impact will be felt for years to come. As he continues to push the boundaries of dermatological science, his work stands as a testament to his unwavering commitment to medical advancement and improved patient outcomes.

Guohua Yang | Medical Genetics | Best Researcher Award

Posted on 07/02/202507/02/2025 by Pencis

Assoc. Prof. Dr. Guohua Yang | Medical Genetics | Best Researcher Award

Wuhan University | China

Author Profile

ORCID ID

🔬🧬 Prof. Guohua Yang – Associate Professor, Wuhan University

Expert in Medical Genetics & Precision Medicine

🏛️ Institution: Wuhan University
🎓 Academic Focus: Medical Genetics, Gene Mutation & Disease Mechanisms

🔍 Research Interests:

🧬 Gene Mutations & Genetic Diseases – Understanding the functional impact of genetic variations.
🏥 Innovative Gene Diagnosis – Developing cutting-edge diagnostic methods for hereditary conditions.
🦠 Hepatocellular Carcinoma – Investigating molecular mechanisms and drug discovery strategies.

📌 Leadership & Professional Roles:

👨‍⚕️ Chairman, Gene Health Branch, Hubei Genetic Society
🏥 Standing Committee Member, Reproductive Genetics Branch, Hubei Reproductive Health Society
🧑‍⚕️ Member, Medical Genetics Branch, Hubei Medical Association
👶 Committee Member, Fertility Protection & Restoration, China Association for Healthy Children
🏥 Deputy Director, Precision Medicine Committee, Zhongguancun Cancer Minimally Invasive Treatment Alliance

📚 Editorial Appointments:

✍️ Guest Editor, Frontiers in Genetics (Monogenic Diseases Column)
📖 Editorial Board Member, Spandidos Journal, Brain Research

🏆CONCLUSION

Prof. Guohua Yang is a leading expert in medical genetics and precision medicine, making significant contributions to gene mutation research, innovative genetic diagnostics, and hepatocellular carcinoma treatment. As a key figure in multiple academic and professional organizations, his leadership and editorial roles further strengthen his impact in the field. His dedication to advancing genetic research and clinical applications continues to shape the future of genomic medicine and personalized healthcare. 🏥🧬

📊🔬NOTABLE PUBLICATION:

Title: Clinic Examination and Gene Diagnosis for a Birt–Hogg–Dubé Syndrome Family With a Novel FLCN Frameshift Mutation Causing Nonsense‐Mediated mRNA Degradation.
Authors: Yang Xu, Jie Gao, Yang An, Chenxi Zou, Guoqing Ding, Guohua Yang, Finlay Macrae.
Journal: Human Mutation
Year: 2025

Title: A Novel TSC1 Frameshift Mutation c.1550_1551del Causes Tuberous Sclerosis Complex by Aberrant Splicing and Nonsense‐Mediated mRNA Degradation (NMD) Simultaneously in a Chinese Family.
Authors: Cong Qiu, Chengyan Li, Xiaoyun Tong, Luoyang Dai, Wenda Liu, Yulie Xie, Qimei Zhang, Guohua Yang, Tao Li.
Journal: Molecular Genetics & Genomic Medicine
Year: 2020

Title: Identification and Interaction Analysis of Significant Genes and MicroRNAs in Pterygium.
Authors: Siying He, Hui Sun, Yifang Huang, Shiqi Dong, Chen Qiao, Shuai Zhang, Chen Wang, Fang Zheng, Ming Yan, Guohua Yang.
Journal: BioMed Research International
Year: 2019

Yong Qian | Nanomedicine | Best Researcher Award

Posted on 04/02/202504/02/2025 by Pencis

Dr. Yong Qian | Nanomedicine | Best Researcher Award

Hefei Institute of Physical Science, Chinese Academy of Sciences | China

AUTHOR PROFILE

Scopus

YONG QIAN 📚

🎓EARLY ACADEMIC PURSUITS

Yong Qian embarked on his academic journey at Anhui University of Technology, where he earned a Bachelor’s degree in Materials Science and Engineering (2014-2018). He further honed his expertise by pursuing a Master’s degree at the University of Anhui (2018-2021), delving deeper into materials science. His passion and commitment led him to achieve a Doctorate in Materials Science and Engineering from the prestigious University of Science and Technology of China (2021-2024).

🏢PROFESSIONAL ENDEAVORS

Currently serving as a Postdoctoral Researcher at the Hefei Institute of Physical Science, Chinese Academy of Sciences since June 2024, Yong Qian is engaged in pioneering research within the field of materials science. His role involves conducting advanced experimental studies, collaborating with interdisciplinary teams, and contributing to groundbreaking projects aimed at innovating material applications.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON NANOMEDICINE

Yong Qian’s research focuses on the development and application of novel materials, particularly exploring their potential in energy storage and conversion systems. His work is characterized by a deep understanding of material properties and innovative approaches to solving real-world challenges. He has actively contributed to the enhancement of materials with improved efficiency and sustainability.

🌟IMPACT AND INFLUENCE

Through his rigorous research efforts, Yong Qian has influenced both academic and industrial communities. His findings have been published in several high-impact journals, contributing valuable knowledge to the field of materials science. He has also participated in international conferences, presenting his work to a global audience and fostering collaborations.

📈ACADEMIC CITES AND RECOGNITION

Yong Qian’s research outputs have garnered significant attention, resulting in numerous citations that highlight the relevance and impact of his work. His contributions have been acknowledged by peers and senior researchers, establishing him as a promising figure in materials science.

🌍LEGACY AND FUTURE CONTRIBUTIONS

Looking ahead, Yong Qian aims to expand his research into sustainable materials for environmental applications, with a particular focus on renewable energy technologies. His vision is to lead projects that bridge the gap between fundamental research and practical applications, ensuring that scientific advancements contribute to global sustainability goals.

🏆CONCLUSION

Yong Qian’s journey from academic excellence to professional innovation underscores his dedication to materials science. His contributions to research and sustainability efforts reflect his commitment to making a meaningful impact. With a strong foundation and a forward-thinking vision, he is poised to drive significant advancements in his field, inspiring future generations of researchers.

📊🔬NOTABLE PUBLICATION:

1. Title: Hollow Cuprous Oxide@Nitrogen-Doped Carbon Nanocapsules for Cascade Chemodynamic Therapy
  Authors: Meng, X.; Zhou, K.; Qian, Y.; … Qian, J.; Wang, H.
  Journal: Small
  Year: 2022

1. Title: NIR-II Responsive PEGylated Nickel Nanoclusters for Photothermal Enhanced Chemodynamic Synergistic Oncotherapy
  Authors: Qian, Y.; Zhang, J.; Zou, J.; … Lin, W.; Wang, H.
  Journal: Theranostics
  Year: 2022

1. Title: Ultrasmall Cu Nanocrystals Dispersed in Nitrogen-Doped Carbon as Highly Efficient Catalysts for CO₂ Electroreduction
  Authors: Meng, X.; Pan, G.; Liu, H.; … Wang, H.; Chen, Q.
  Journal: ACS Applied Materials and Interfaces
  Year: 2022

1. Title: Carbon-Encapsulated Magnetite Nanodoughnut as a NIR-II Responsive Nanozyme for Synergistic Chemodynamic–Photothermal Therapy
  Authors: Meng, X.; Zhang, Z.; Qian, Y.; … Zhang, M.; Wang, H.
  Journal: Advanced Healthcare Materials
  Year: 2023

1. Title: Magnetic Field-Induced Synthesis of One-Dimensional Nickel Nanowires for Enhanced Microwave Absorption
  Authors: Qian, Y.; Meng, X.; Liu, H.; … Sheng, Z.; Wang, H.
  Journal: Advanced Materials Interfaces
  Year: 2023